Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
The Down Low: Curbing the HIV Epidemic in Rural Louisiana
African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...
Can Pet Visits Help Kids With Cancer?
We are in the home stretch! Please consider donating in these final hours so that we'll be able to...
Managing Congenital Adrenal Hyperplasia in the Amish Population
Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...